SIRPα blockade improves the antitumor immunity of radiotherapy in colorectal cancer
Cited by 19
Related Papers
hnRNP A1 inhibits colorectal cancer tumorigenesis and progression by regulating fatty acid metabolism and RNA stability
|Cell Death Discovery|2025|1
SIRPα Blockade Improves the Antitumor Immunity of Radiotherapy in Colorectal Cancer
|Research Square|2022|0